Cell Therapies and Immunotherapy Conference | AIChE

This conference will address challenges and discoveries in the cell therapy and immunotherapy fields that will ultimately change the future of healthcare.

Abstract Deadline: Sunday, September 1, 2019

Submit an Abstract

Submit Your Abstract Now!

Get your submission in as soon as possible for review by the organizing committee.

Session Topics

  • Update From the Frontline CARs in the Clinic - Disease specific differences in outcomes and safety, real-world experience with CD28 vs. 4-1BB, solid vs heme

  • Mechanisms of Relapse and Strategies to Overcome - Antigen escape, tumor heterogeneity, T cell quality and persistence

  • Beyond Conventional CARs - Alternative CAR architectures, split CARs, TCRs, combination therapies

  • Gene Editing in Cell Therapy - ​Applications of editing, novel technologies, regulatory considerations for gene edited products

  • Moving Beyond Autologous T cells Allogeneic and Other Cell Types - ​Allogeneic approaches, gd T cells, NK cells, iPSC derived products

  • Solid tumors Increasing Specificity and Overcoming TME - Strategies to enhance tumor specificity, increase T cell trafficking, persistence, and potency

  • Bigger, Stronger, Faster Synthetic Biology Approaches to Develop more Potent Therapies - Building synthetic gene circuits, delivering therapeutic payloads, armored CARs

  • Cell Therapy Applications Beyond Oncology - Using cells as therapeutics in autoimmune disease, CAR Tregs, etc.

Session Topics

  • Update From the Frontline CARs in the Clinic - Disease specific differences in outcomes and safety, real-world experience with CD28 vs. 4-1BB, solid vs heme

  • Mechanisms of Relapse and Strategies to Overcome - Antigen escape, tumor heterogeneity, T cell quality and persistence

  • Beyond Conventional CARs - Alternative CAR architectures, split CARs, TCRs, combination therapies

  • Gene Editing in Cell Therapy - ​Applications of editing, novel technologies, regulatory considerations for gene edited products

  • Moving Beyond Autologous T cells Allogeneic and Other Cell Types - ​Allogeneic approaches, gd T cells, NK cells, iPSC derived products

  • Solid tumors Increasing Specificity and Overcoming TME - Strategies to enhance tumor specificity, increase T cell trafficking, persistence, and potency

  • Bigger, Stronger, Faster Synthetic Biology Approaches to Develop more Potent Therapies - Building synthetic gene circuits, delivering therapeutic payloads, armored CARs

  • Cell Therapy Applications Beyond Oncology - Using cells as therapeutics in autoimmune disease, CAR Tregs, etc.

AIChE Member Events Discount

Did you know that annual AIChE memberships offer great discounts on conferences and events? Become a member and the discount to this one event will practically cover the rest of the year!